Text Size

Consultations in Adapted Physical Activity on Behaviours in Physical Exercise by Type 2 Diabetics

This study has been completed.
Sponsor:
Collaborator:
National Institut of Prevention and Health Education
Information provided by:
University Hospital, Grenoble
ClinicalTrials.gov Identifier:
NCT00403741
First received: November 24, 2006
Last updated: February 26, 2010
Last verified: February 2010
History of Changes
  Purpose

Assesment the impact of three individuals consultations in adapted physical activity by type 2 diabetics


Condition Intervention
Diabetes Mellitus, Type 2
 Behavioral: motivational interviewing

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Effects of Individuals Consultations in Adapted Physical Activity on Behaviours in Physical Exercise by Type 2 Diabetics

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University Hospital, Grenoble:

Primary Outcome Measures:
  • Score on Treatment Self-Regulation Questionnaire(TSRQ)at Treatment Self-Regulation Questionnaire (TSRQ) at 3 months, 9 months and 15 months after assesment's day of the education period.

Secondary Outcome Measures:
  • Modifiable Activity Questionnaire(MAQ)at 3 months, 9 months and 15 months after assesment's day of the education period.
  • Perceveid Competence Scale (PCS)at assesment's day of the education period and at 3 months, 9 months and 15 months after assesment's day of the education period.
  • Interpersonal behaviors scale at assesment's day of the education period and at 3 months, 9 months and 15 months after assesment's day of the education period.
  • Diabetes Quality of Life (DQOL) at assesment's day of the education period and at 15 months after assesment's day of the education period.
  • Diabetes Locus of Control Scale (DLCS)at assesment's day of the education period and at 15 months after assesment's day of the education period.
  • HbA1c et lipid profile at 3 months, 9 months and 15 months after assesment's day of the education period.

Estimated Enrollment: 120
Study Start Date: January 2007
Study Completion Date: July 2009
Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • type 2 diabetics
  • age < 80 years
  • to be able to read and to understand French
  • to be affiliate national insurance
  • to give a light and read consent

Exclusion Criteria:

  • incapacity to carry out a questionnaire
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00403741

Sponsors and Collaborators
University Hospital, Grenoble
National Institut of Prevention and Health Education
Investigators
Principal Investigator: HALIMI SH Serge, PU-PH University Hospital, Grenoble
  More Information

No publications provided

Responsible Party: HALIMI Serge, Professor, University Hospital, Grenoble
ClinicalTrials.gov Identifier: NCT00403741     History of Changes
Other Study ID Numbers: 0621
Study First Received: November 24, 2006
Last Updated: February 26, 2010
Health Authority: France: Ministry of Health

Keywords provided by University Hospital, Grenoble:
behavior
physical activity
motivation

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on May 19, 2013